Stephen B. Shohet is Director at Amphastar Pharmaceuticals, Inc. (AMPH). They have made 4 open-market trades across 1 company since 2014, most recently 2018-12-10.
CIK 0001611281
1 open-market purchase totalling $36K since 2014, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMPH | 89,263 | $2.5M |
Shares reported on the most recent Form 4, priced at the 2018-12-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMPH | SELL | 2018-12-10 | 2018-12-12 | $21.72 | $1.3M | -10.2% | +4.3% | +14.0% |
| AMPH | SELL · 10b5-1 | 2017-12-14 | 2017-12-14 | $18.87 | $148K | +5.4% | +0.2% | +8.0% |
| AMPH | SELL · 10b5-1 | 2017-12-07 | 2017-12-08 | $18.34 | $144K | +4.4% | -2.5% | +1.6% |
| AMPH | SELL · 10b5-1 | 2017-11-30 | 2017-11-30 | $19.25 | $151K | -1.7% | -2.2% | -6.3% |
| AMPH | SELL · 10b5-1 | 2017-11-22 | 2017-11-24 | $18.94 | $149K | +0.1% | +7.2% | +2.8% |
| AMPH | SELL · 10b5-1 | 2017-11-16 | 2017-11-17 | $18.04 | $142K | +7.6% | +7.3% | +4.6% |
| AMPH | SELL | 2017-11-09 | 2017-11-09 | $18.55 | $290K | +0.8% | -0.7% | -4.2% |
| AMPH | SELL · 10b5-1 | 2017-11-02 | 2017-11-03 | $18.37 | $144K | -6.7% | -1.4% | -1.1% |
| AMPH | SELL · 10b5-1 | 2017-10-26 | 2017-10-26 | $18.39 | $145K | -3.2% | -2.4% | +4.5% |
| AMPH | SELL · 10b5-1 | 2017-10-19 | 2017-10-19 | $18.34 | $144K | -2.5% | -1.1% | +4.9% |
| AMPH | SELL · 10b5-1 | 2017-10-12 | 2017-10-13 | $18.73 | $147K | -2.9% | -4.6% | -3.0% |
| AMPH | SELL | 2016-08-12 | 2016-08-16 | $18.24 | $882K | +6.0% | +1.8% | +11.9% |
| AMPH | SELL · 10b5-1 | 2015-12-16 | 2015-12-17 | $14.19 | $437K | -12.7% | -14.4% | -13.6% |
| AMPH | SELL · 10b5-1 | 2015-07-17 | 2015-07-21 | $17.41 | $134K | -12.7% | -2.5% | -2.5% |
| AMPH | BUY | 2014-08-15 | 2014-08-19 | $10.37 | $36K | -12.7% | -2.5% | -2.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.